What Is Depression? Symptoms, Causes, and Why Getting the Right Help Takes So Long

Depression is not what most people picture when they hear the word.

The standard image is persistent sadness. But many people with clinical depression describe something closer to numbness, or a complete loss of interest in anything that used to matter. Some describe it as physical: a heaviness that makes getting out of bed feel like an athletic event. Others experience it as irritability, or as an inability to think clearly, or as the feeling that they are watching their life from behind glass.

What all of these experiences share is not a particular emotion but a specific biology, a persistent disruption in the systems the brain uses to regulate mood, motivation, energy, sleep, and cognition. Understanding that biology is not just academic. It is the reason depression does not resolve by thinking positively, and it is why the right clinical care changes outcomes in ways that willpower alone cannot.

What This Page Covers

• What depression actually is, clinically
• The nine core symptoms, and how they present in real life
• The main types of depression
• What causes depression, and what the neuroscience shows
• Who gets depression and when
• How depression is diagnosed
• How it is treated, and what the evidence shows
• The care gap that explains why so many people don’t get better
• How SiggyMD approaches ongoing depression care

What Depression Actually Is

Depression, at its clinical core, is a persistent disruption in the brain systems that regulate mood and motivation.

The formal name is major depressive disorder (MDD). The experience is something most people recognize but underestimate in its severity. An estimated 21.0 million adults in the United States had at least one major depressive episode in 2021, representing 8.3% of all U.S. adults. Over a lifetime, approximately one in five people will meet criteria for depression.

Depression is not a response to specific circumstances. It can begin with a triggering event, but it can also develop without one. And unlike ordinary sadness, it does not lift when circumstances improve. Depression requires that core symptoms occur for most of the day, nearly every day, for more than two weeks, along with a clear change in day-to-day functioning.

The condition is episodic for many people, meaning it comes in waves. A national survey of 36,309 U.S. adults found that 12-month and lifetime prevalences of major depressive disorder were 10.4% and 20.6%, respectively. Most episodes, untreated, last six to twelve months. And with each episode, the risk of a future one increases.

The Nine Core Symptoms (and What They Actually Feel Like)

The diagnostic threshold for major depressive disorder requires five or more of the following nine symptoms, present most of the day, nearly every day, for at least two weeks. One of the five must be either depressed mood or loss of interest.

Persistent depressed mood is what most people associate with depression. But many people with clinical depression don’t feel sad in the conventional sense. They feel flat, empty, or as though they cannot access emotions they know they should be feeling.

Loss of interest or pleasure refers to anhedonia: the inability to feel engaged by or rewarded from activities that used to matter. A person who loved reading and can no longer open a book. A parent who feels nothing watching their child play. This is often the most striking symptom to people around the person.

Significant changes in weight or appetite: depression changes how the brain processes hunger and food reward. Some people lose weight and barely eat; others develop cravings and overeat.

Sleep changes: depression commonly produces either insomnia (particularly early morning awakening) or hypersomnia (sleeping ten or twelve hours and still feeling unrested). Sleep changes often precede mood changes in antidepressant response and can serve as an early monitoring signal.

Fatigue and energy loss: the fatigue in depression is not tiredness. It is a pervasive heaviness that makes small tasks feel enormous. Getting dressed, answering an email, making a phone call, all become effortful in a way that is genuinely physical.

Psychomotor changes: these are visible to others. Slowed speech and movement, or agitation. People may notice a person is speaking more slowly than usual, pausing longer between words, or moving restlessly.

Feelings of worthlessness or excessive guilt: depression distorts self-perception in a consistent direction. People ruminate on past failures, blame themselves for events that were not their fault, and hold themselves to standards they would not apply to anyone else.

Difficulty concentrating or making decisions: cognitive symptoms of depression are underrecognized. Many people first present to a physician complaining of memory problems or inability to focus, not sadness.

Recurrent thoughts of death or suicidal ideation: ranging from passive thoughts about death to active suicidal ideation. Any thoughts of this kind require prompt clinical attention. If you are experiencing thoughts of suicide, call or text 988 to reach the Suicide and Crisis Lifeline, available 24 hours a day. In life-threatening situations, call 911.

Types of Depression

Major depressive disorder is the most common form, but depression takes several clinical shapes.

Persistent depressive disorder (formerly dysthymia) involves chronically depressed mood lasting most of the day, for more days than not, over at least two years. The symptoms are often less intense than a full MDD episode but last far longer and can be equally impairing.

Seasonal affective disorder follows a regular seasonal pattern, typically beginning in fall or winter and remitting in spring. It is more than a winter mood dip. It meets full diagnostic criteria for MDD and responds to treatment.

Postpartum depression affects approximately 10 to 15% of women following childbirth, though it can affect any parent. It is distinct from the “baby blues,” which typically resolve within two weeks. Postpartum depression requires clinical treatment.

Depression with anxious distress recognizes that many people with depression also experience significant anxiety. Research shows that anxious depression tends to be more severe, more disabling, and more treatment-resistant than non-anxious depression.

Depression with psychotic features involves depression severe enough to produce hallucinations or delusions. This presentation requires specific treatment adjustments.

Researchers are also developing more precise frameworks. A 2024 Nature Medicine study using brain imaging and machine learning identified six distinct biological subtypes of depression and anxiety, with different neural circuit patterns and different responses to specific treatments. This work suggests that “depression” as a category may eventually be subdivided by biology in ways that improve treatment matching.

What Causes Depression

Depression does not have a single cause. The evidence points to an interaction of biological, genetic, psychological, and environmental factors. Each plays a role, and the combination differs across people.

Neurobiology. The brain’s monoamine systems, particularly serotonin, norepinephrine, and dopamine, regulate mood, motivation, sleep, and reward. Current neurobiological theories of depression based on solid empirical evidence point to the interaction of psychosocial stress, neurotransmitter dysregulation, and neuroendocrine changes as central to MDD pathophysiology. These are not separate theories but overlapping mechanisms.

The HPA axis (hypothalamic-pituitary-adrenal) is the body’s primary stress response system. Hyperactivity of the HPA axis is among the most typical neurobiological alterations in depressed individuals, involving elevated cortisol that produces structural brain changes including reduced hippocampal neurogenesis. Chronic stress drives this system into persistent overactivation, which is one mechanism linking early trauma and later depression risk.

Inflammation increasingly appears in depression research as well. Recent advances have expanded our understanding of MDD beyond neurotransmitter imbalances to include inflammatory pathways, gut-brain axis interactions, and neuroplasticity mechanisms.

Genetics. Depression runs in families. If one identical twin has depression, the other has a 70 percent chance of having the illness sometime in life. Risk roughly doubles if a first-degree relative has experienced depression. But genetics sets susceptibility, not destiny. Environment and life experience shape whether the predisposition expresses.

Life events and environment. Traumatic experiences, particularly in childhood, have lasting effects on HPA axis sensitivity. Chronic stress, relationship loss, financial difficulty, and social isolation all increase risk. So do certain medical conditions, including thyroid disorders, cardiovascular disease, and chronic pain.

Who Gets Depression

Depression affects people of every age, race, income level, and background. However, patterns exist in who is more likely to experience it.

The prevalence of depression is higher in females (16.0%) than in males (10.1%) overall, and depression prevalence was higher in younger adults, with those ages 12-19 showing the highest rates. This gender gap is real but not total. Men often experience depression differently, showing higher rates of irritability, anger, and substance use rather than classic sadness, and are less likely to seek help.

Socioeconomic factors play a significant role. Lower income is associated with higher depression rates, higher severity, and lower rates of receiving evidence-based treatment. The connection runs in multiple directions: depression reduces earning capacity, and financial stress increases depression risk.

Depression is also more common in people with chronic physical illness. Cardiovascular disease, diabetes, chronic pain, and cancer all substantially increase depression risk. And depression, in turn, worsens outcomes in those conditions.

How Depression Is Diagnosed

There is no blood test for depression. Diagnosis is clinical: a trained clinician conducts a structured interview that assesses symptoms, duration, functional impact, and rules out other causes.

The evaluation typically covers:

Current symptoms and their duration. A diagnosis of major depressive disorder requires at least five of the nine core symptoms, including depressed mood or loss of interest, present most of the day, nearly every day, for at least two weeks.

Functional impact. Symptoms must cause meaningful disruption to work, relationships, or daily activities. A diagnosis cannot be made on symptom count alone.

Medical screening. Thyroid disorders, vitamin D deficiency, hormonal shifts, certain medications, and neurological conditions can produce symptoms that look like depression. A complete evaluation includes a physical examination and often basic laboratory tests.

History of prior episodes and family history.

Ruling out bipolar disorder. A single depressive episode does not tell you whether the person has unipolar depression or is experiencing the depressive phase of bipolar disorder. Getting this distinction right matters because some antidepressants can destabilize bipolar disorder. A clinician will ask about periods of elevated mood, decreased need for sleep, and increased activity that might indicate prior hypomanic or manic episodes.

Validated screening tools like the PHQ-9 support clinical judgment but do not replace it. A score of 10 or higher on the PHQ-9 signals clinically significant depressive symptoms, but diagnosis requires the full clinical picture.

How Depression Is Treated

Depression is among the most treatable conditions in psychiatry. Between 70% and 90% of people with depression eventually respond well to treatment.

Antidepressant medications. SSRIs and SNRIs are the clinical standard for moderate to severe depression. A network meta-analysis of 522 randomized controlled trials comprising 116,477 participants found that all 21 antidepressants evaluated were more effective than placebo, with ORs ranging from 2.13 for amitriptyline to 1.37 for reboxetine. Escitalopram and sertraline combined the best balance of efficacy and tolerability.

SSRIs block the reuptake of serotonin, increasing its availability at the synapse. The therapeutic effect for mood develops over two to six weeks, through downstream changes in neuroplasticity, not through immediate chemical flooding. SNRIs add norepinephrine reuptake blockade, which is useful for patients with prominent physical symptoms, fatigue, or chronic pain.

Clinical improvement with most antidepressants is expected in the first six weeks from initial dosing. Psychiatrists generally recommend continuation of medication for six to nine months after achieving remission, and longer for people with multiple prior episodes.

Psychotherapy. Cognitive behavioral therapy (CBT) is the best-studied psychological treatment for depression. It teaches skills to identify and reframe negative thought patterns and break behavioral cycles that maintain depression. For mild to moderate depression, CBT is as effective as medication for many patients. For moderate to severe depression, combination treatment, medication plus therapy, produces better outcomes than either approach alone.

Brain stimulation therapies. For severe depression that has not responded to medication or therapy, FDA-cleared options include electroconvulsive therapy (ECT) and transcranial magnetic stimulation (TMS). These are typically reserved for cases where multiple medication trials have failed.

The Gap Between Starting Treatment and Getting Better

Here is the part that most pages on depression skip.

Depression is treatable. That statement is true. But it misses a critical reality: starting treatment is not the same as completing it.

Approximately 25% of patients discontinue antidepressant treatment within one month, and 44% discontinue within three months of initiating therapy. Most stop not because the medication is wrong, but because side effects in the early weeks are unmanaged, because no one checks in to see if it is working, and because the structure of quarterly appointments cannot catch a patient who is quietly heading toward dropout.

The mean delay from depression symptom onset to first treatment contact is measured in years, not months. People wait. They minimize their symptoms. They try to manage on their own. And when they finally receive a prescription, that prescription is often the end of the clinical engagement rather than the beginning of it.

This is not an individual failure. It is a structural one. The current standard of care for depression was designed around the assumption that patients would return for follow-up appointments when they felt they needed them. That assumption is wrong. Most patients who drop out of treatment do not return until the next crisis.

What changes this picture is continuous support. A system that tracks how a medication is working week by week. That catches side effects early. That reinforces why the treatment is worth continuing at exactly the moment a patient is most likely to stop.

“The hardest moment in depression treatment is not the beginning,” says Shannon Carres, Psych P.A., of the SiggyMD clinical team. “It is the four-to-six-week mark, when side effects may still be present but the therapeutic benefit hasn’t fully arrived yet. Patients who have no one checking in at that moment are the ones most likely to stop. And stopping at that point, before the medication has had time to work, means starting over.”

About SiggyMD

SiggyMD provides clinically supervised care for anxiety and depression, built around what actually predicts whether treatment works: ongoing monitoring, not just an initial prescription.

The process begins with a free, anonymous intake. No login, no name, no email required. You answer a structured clinical interview at your own pace. A licensed prescriber reviews your full intake before anything is prescribed. That review is not automated. A real clinician approves your treatment plan.

After you start treatment, daily check-ins track how the medication is affecting you: sleep, energy, mood, side effects, adherence. Your care team sees that data continuously. If something changes in week three, they know about it in week three, not at the next appointment three months later.

For a complete overview of what to expect from depression medication early on, see our post on how antidepressants work in the first weeks.

What Members Are Saying

RM

R.M., 34

Major Depressive Disorder

“I had been prescribed medication twice before and stopped both times around week four because of nausea and because I didn’t feel anything was changing. No one ever told me that the nausea typically resolves and that the mood benefit takes longer. When I had someone actually checking in on me, I made it through that window for the first time. That was the difference.”

KP

K.P., 41

Depression with Anxious Features

“I spent almost two years convinced I didn’t need medication. I kept thinking I could manage with exercise and sleep. When I finally did the intake and a prescriber reviewed my situation, she explained exactly why my symptoms had the pattern they did and what medication would actually address the specific mechanism. That conversation alone changed how I thought about it.”

Member stories reflect real experiences. Names and identifying details have been changed to protect privacy. Results vary. You can begin anonymous intake without an account, name, email, or payment.

Ready to Get Support That Stays With You?

Depression is treatable. The evidence on that is clear. What the evidence also shows is that treatment outcomes depend heavily on what happens after the initial prescription: whether someone is monitoring how the medication is working, whether side effects are caught early, whether you have clinical support at the moment you are most likely to stop.

SiggyMD exists to close that gap. Free, anonymous intake. A licensed prescriber who reviews your full clinical picture before anything is prescribed. Daily check-ins that give your care team a real view of how treatment is working, not a reconstructed account three months later.

Start your anonymous intake with SiggyMD and talk to a prescriber who has your full history from day one.

Sources

1. National Institute of Mental Health. Major Depression Statistics. NIMH. Accessed June 2026.

2. Hasin DS, et al. Epidemiology of Adult DSM-5 Major Depressive Disorder and Its Specifiers in the United States. JAMA Psychiatry. 2018;75(4):336-346.

3. American Psychiatric Association. What Is Depression? APA. Accessed June 2026.

4. Cipriani A, et al. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. The Lancet. 2018;391(10128):1357-1366.

5. Dell’Osso B, et al. How to improve adherence to antidepressant treatments in patients with major depression: a psychoeducational consensus checklist. Annals of General Psychiatry. 2020;19(1):61.

6. Saveanu RV, Nemeroff CB. Etiology of depression: genetic and environmental factors. Psychiatric Clinics of North America. 2012;35(1):51-71.

7. National Center for Health Statistics. Depression Prevalence in Adolescents and Adults. CDC Data Brief 527. 2024.

8. Williams LM, et al. Personalized brain circuit scores identify clinically distinct biotypes in depression and anxiety. Nature Medicine. 2024;30:2076-2087.

9. Frontiers in Neuroscience. Hypothalamus-pituitary-adrenal and gut-brain axes in biological interaction pathway of the depression. 2025.

10. Signal Transduction and Targeted Therapy. Major depressive disorder: hypothesis, mechanism, prevention and treatment. 2024.